Silymarin-loaded chitosan nanoparticles alleviate dyslipidemia, oxidative stress, metabolic disturbance and histopathological injury associated with high fat diet-induced non-alcoholic fatty liver disease in rats

With an increasing incidence of obesity and metabolic syndrome epidemic, nonalcoholic fatty liver disease (NAFLD) continues to be one of the most prevalent liver illnesses worldwide. One of recommended treatment in NAFLD is silymarin. Howerver, the problem is that silymarin has weak water solubilit...

Full description

Bibliographic Details
Main Authors: Mohamed Fouad Mansour, Zaher Z. Radwan, Tarek Khamis, Medhat Fawzy
Format: Article
Language:English
Published: Assiut University 2024-03-01
Series:Journal of Advanced Veterinary Research
Subjects:
Online Access:https://www.advetresearch.com/index.php/AVR/article/view/1693